APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bradykinin B1 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bradykinin B1 Receptor Market Analysis and Forecast 2026-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchBradykinin B1 Receptor Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal Bradykinin B1 Receptor Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Bradykinin B1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bradykinin B1 Receptor Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Bradykinin B1 Receptor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Bradykinin B1 Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bradykinin B1 Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bradykinin B1 Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bradykinin B1 Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bradykinin B1 Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bradykinin B1 Receptor include Grunenthal GmbH, Dompe Farmaceutici S.p.A., Boehringer Ingelheim GmbH and Axxam SpA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bradykinin B1 Receptor, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bradykinin B1 Receptor, also provides the revenue of main regions and countries. Of the upcoming market potential for Bradykinin B1 Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bradykinin B1 Receptor revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bradykinin B1 Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bradykinin B1 Receptor revenue, projected growth trends, production technology, application and end-user industry.

Bradykinin B1 Receptor Segment by Company

Grunenthal GmbH

Dompe Farmaceutici S.p.A.

Boehringer Ingelheim GmbH

Axxam SpA

Bradykinin B1 Receptor Segment by Type

BI-113823

Others

Bradykinin B1 Receptor Segment by Application

Clinic

Hospital

Household

Bradykinin B1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bradykinin B1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bradykinin B1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bradykinin B1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bradykinin B1 Receptor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bradykinin B1 Receptor company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bradykinin B1 Receptor revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bradykinin B1 Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. BI-113823 Major Player Table 3. Others Major Player Table 4. Global Bradykinin B1 Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Player Table 6. Hospital Major Player Table 7. Household Major Player Table 8. Bradykinin B1 Receptor Industry Trends Table 9. Bradykinin B1 Receptor Industry Drivers Table 10. Bradykinin B1 Receptor Industry Opportunities and Challenges Table 11. Bradykinin B1 Receptor Industry Restraints Table 12. Global Bradykinin B1 Receptor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Bradykinin B1 Receptor Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Bradykinin B1 Receptor Market Share by Region (2021-2026) Table 15. Global Bradykinin B1 Receptor Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Bradykinin B1 Receptor Market Share by Region (2027-2032) Table 17. Global Bradykinin B1 Receptor Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Bradykinin B1 Receptor Revenue Market Share by Players (2021-2026) Table 19. Global Bradykinin B1 Receptor Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Bradykinin B1 Receptor Key Players Headquarters & Area Served Table 21. Global Bradykinin B1 Receptor Players, Product Type & Application Table 22. Global Bradykinin B1 Receptor Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Bradykinin B1 Receptor by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Bradykinin B1 Receptor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bradykinin B1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Bradykinin B1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Bradykinin B1 Receptor Revenue Market Share by Type (2021-2026) Table 29. Global Bradykinin B1 Receptor Revenue Market Share by Type (2027-2032) Table 30. Global Bradykinin B1 Receptor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Bradykinin B1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Bradykinin B1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Bradykinin B1 Receptor Revenue Market Share by Application (2021-2026) Table 34. Global Bradykinin B1 Receptor Revenue Market Share by Application (2027-2032) Table 35. Grunenthal GmbH Company Information Table 36. Grunenthal GmbH Business Overview Table 37. Grunenthal GmbH Bradykinin B1 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Grunenthal GmbH Bradykinin B1 Receptor Product Portfolio Table 39. Grunenthal GmbH Recent Development Table 40. Dompe Farmaceutici S.p.A. Company Information Table 41. Dompe Farmaceutici S.p.A. Business Overview Table 42. Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Product Portfolio Table 44. Dompe Farmaceutici S.p.A. Recent Development Table 45. Boehringer Ingelheim GmbH Company Information Table 46. Boehringer Ingelheim GmbH Business Overview Table 47. Boehringer Ingelheim GmbH Bradykinin B1 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Boehringer Ingelheim GmbH Bradykinin B1 Receptor Product Portfolio Table 49. Boehringer Ingelheim GmbH Recent Development Table 50. Axxam SpA Company Information Table 51. Axxam SpA Business Overview Table 52. Axxam SpA Bradykinin B1 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Axxam SpA Bradykinin B1 Receptor Product Portfolio Table 54. Axxam SpA Recent Development Table 55. North America Bradykinin B1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 56. North America Bradykinin B1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 57. North America Bradykinin B1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 58. North America Bradykinin B1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 59. North America Bradykinin B1 Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 60. North America Bradykinin B1 Receptor Revenue by Country (2021-2026) & (US$ Million) Table 61. North America Bradykinin B1 Receptor Revenue by Country (US$ Million) & (2027-2032) Table 62. Europe Bradykinin B1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 63. Europe Bradykinin B1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 64. Europe Bradykinin B1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 65. Europe Bradykinin B1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 66. Europe Bradykinin B1 Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 67. Europe Bradykinin B1 Receptor Revenue by Country (2021-2026) & (US$ Million) Table 68. Europe Bradykinin B1 Receptor Revenue by Country (US$ Million) & (2027-2032) Table 69. China Bradykinin B1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 70. China Bradykinin B1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 71. China Bradykinin B1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 72. China Bradykinin B1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 73. Asia Bradykinin B1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 74. Asia Bradykinin B1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 75. Asia Bradykinin B1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 76. Asia Bradykinin B1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 77. Asia Bradykinin B1 Receptor Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Asia Bradykinin B1 Receptor Revenue by Region (US$ Million) & (2021-2026) Table 79. Asia Bradykinin B1 Receptor Revenue by Region (US$ Million) & (2027-2032) Table 80. SAMEA Bradykinin B1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 81. SAMEA Bradykinin B1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 82. SAMEA Bradykinin B1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 83. SAMEA Bradykinin B1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 84. SAMEA Bradykinin B1 Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. SAMEA Bradykinin B1 Receptor Revenue by Country (2021-2026) & (US$ Million) Table 86. SAMEA Bradykinin B1 Receptor Revenue by Country (US$ Million) & (2027-2032) Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Bradykinin B1 Receptor Image Figure 2. Global Bradykinin B1 Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bradykinin B1 Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 4. BI-113823 Image Figure 5. Others Image Figure 6. Global Bradykinin B1 Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bradykinin B1 Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Household Image Figure 11. Global Bradykinin B1 Receptor Market Size (US$ Million) & (2021-2032) Figure 12. Global Bradykinin B1 Receptor Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Bradykinin B1 Receptor Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Bradykinin B1 Receptor Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Bradykinin B1 Receptor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Bradykinin B1 Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Bradykinin B1 Receptor Revenue Market Share by Type (2021-2032) Figure 19. Global Bradykinin B1 Receptor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Bradykinin B1 Receptor Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Bradykinin B1 Receptor Revenue Market Share by Application (2021-2032) Figure 22. North America Bradykinin B1 Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Bradykinin B1 Receptor Revenue Share by Type (2021-2032) Figure 24. North America Bradykinin B1 Receptor Revenue Share by Application (2021-2032) Figure 25. North America Bradykinin B1 Receptor Revenue Share by Country (2021-2032) Figure 26. United States Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Bradykinin B1 Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Bradykinin B1 Receptor Revenue Share by Type (2021-2032) Figure 31. Europe Bradykinin B1 Receptor Revenue Share by Application (2021-2032) Figure 32. Europe Bradykinin B1 Receptor Revenue Share by Country (2021-2032) Figure 33. Germany Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Bradykinin B1 Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Bradykinin B1 Receptor Revenue Share by Type (2021-2032) Figure 43. China Bradykinin B1 Receptor Revenue Share by Application (2021-2032) Figure 44. Asia Bradykinin B1 Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Bradykinin B1 Receptor Revenue Share by Type (2021-2032) Figure 46. Asia Bradykinin B1 Receptor Revenue Share by Application (2021-2032) Figure 47. Asia Bradykinin B1 Receptor Revenue Share by Region (2021-2032) Figure 48. Japan Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Bradykinin B1 Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Bradykinin B1 Receptor Revenue Share by Type (2021-2032) Figure 56. SAMEA Bradykinin B1 Receptor Revenue Share by Application (2021-2032) Figure 57. SAMEA Bradykinin B1 Receptor Revenue Share by Country (2021-2032) Figure 58. Brazil Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Bradykinin B1 Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • BI-113823
  • Others
Applications
  • Clinic
  • Hospital
  • Household
Companies covered
  • Grunenthal GmbH
  • Dompe Farmaceutici S.p.A.
  • Boehringer Ingelheim GmbH
  • Axxam SpA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bradykinin B1 Receptor Market by Type
  3. 1.2.1 Global Bradykinin B1 Receptor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 BI-113823
  5. 1.2.3 Others
  6. 1.3 Bradykinin B1 Receptor Market by Application
  7. 1.3.1 Global Bradykinin B1 Receptor Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Household
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Bradykinin B1 Receptor Market Dynamics
  1. 2.1 Bradykinin B1 Receptor Industry Trends
  2. 2.2 Bradykinin B1 Receptor Industry Drivers
  3. 2.3 Bradykinin B1 Receptor Industry Opportunities and Challenges
  4. 2.4 Bradykinin B1 Receptor Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bradykinin B1 Receptor Market Perspective (2021-2032)
  2. 3.2 Global Bradykinin B1 Receptor Growth Trends by Region
  3. 3.2.1 Global Bradykinin B1 Receptor Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bradykinin B1 Receptor Market Size by Region (2021-2026)
  5. 3.2.3 Global Bradykinin B1 Receptor Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bradykinin B1 Receptor Revenue by Players
  2. 4.1.1 Global Bradykinin B1 Receptor Revenue by Players (2021-2026)
  3. 4.1.2 Global Bradykinin B1 Receptor Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bradykinin B1 Receptor Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bradykinin B1 Receptor Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bradykinin B1 Receptor Key Players Headquarters & Area Served
  7. 4.4 Global Bradykinin B1 Receptor Players, Product Type & Application
  8. 4.5 Global Bradykinin B1 Receptor Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bradykinin B1 Receptor Market CR5 and HHI
  11. 4.6.3 2025 Bradykinin B1 Receptor Tier 1, Tier 2, and Tier 3
5 Bradykinin B1 Receptor Market Size by Type
  1. 5.1 Global Bradykinin B1 Receptor Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bradykinin B1 Receptor Revenue by Type (2021-2032)
  3. 5.3 Global Bradykinin B1 Receptor Revenue Market Share by Type (2021-2032)
6 Bradykinin B1 Receptor Market Size by Application
  1. 6.1 Global Bradykinin B1 Receptor Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bradykinin B1 Receptor Revenue by Application (2021-2032)
  3. 6.3 Global Bradykinin B1 Receptor Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Grunenthal GmbH
  2. 7.1.1 Grunenthal GmbH Company Information
  3. 7.1.2 Grunenthal GmbH Business Overview
  4. 7.1.3 Grunenthal GmbH Bradykinin B1 Receptor Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Grunenthal GmbH Bradykinin B1 Receptor Product Portfolio
  6. 7.1.5 Grunenthal GmbH Recent Developments
  7. 7.2 Dompe Farmaceutici S.p.A.
  8. 7.2.1 Dompe Farmaceutici S.p.A. Company Information
  9. 7.2.2 Dompe Farmaceutici S.p.A. Business Overview
  10. 7.2.3 Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Product Portfolio
  12. 7.2.5 Dompe Farmaceutici S.p.A. Recent Developments
  13. 7.3 Boehringer Ingelheim GmbH
  14. 7.3.1 Boehringer Ingelheim GmbH Company Information
  15. 7.3.2 Boehringer Ingelheim GmbH Business Overview
  16. 7.3.3 Boehringer Ingelheim GmbH Bradykinin B1 Receptor Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Boehringer Ingelheim GmbH Bradykinin B1 Receptor Product Portfolio
  18. 7.3.5 Boehringer Ingelheim GmbH Recent Developments
  19. 7.4 Axxam SpA
  20. 7.4.1 Axxam SpA Company Information
  21. 7.4.2 Axxam SpA Business Overview
  22. 7.4.3 Axxam SpA Bradykinin B1 Receptor Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Axxam SpA Bradykinin B1 Receptor Product Portfolio
  24. 7.4.5 Axxam SpA Recent Developments
8 North America
  1. 8.1 North America Bradykinin B1 Receptor Revenue (2021-2032)
  2. 8.2 North America Bradykinin B1 Receptor Revenue by Type (2021-2032)
  3. 8.2.1 North America Bradykinin B1 Receptor Revenue by Type (2021-2026)
  4. 8.2.2 North America Bradykinin B1 Receptor Revenue by Type (2027-2032)
  5. 8.3 North America Bradykinin B1 Receptor Revenue Share by Type (2021-2032)
  6. 8.4 North America Bradykinin B1 Receptor Revenue by Application (2021-2032)
  7. 8.4.1 North America Bradykinin B1 Receptor Revenue by Application (2021-2026)
  8. 8.4.2 North America Bradykinin B1 Receptor Revenue by Application (2027-2032)
  9. 8.5 North America Bradykinin B1 Receptor Revenue Share by Application (2021-2032)
  10. 8.6 North America Bradykinin B1 Receptor Revenue by Country
  11. 8.6.1 North America Bradykinin B1 Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bradykinin B1 Receptor Revenue by Country (2021-2026)
  13. 8.6.3 North America Bradykinin B1 Receptor Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Bradykinin B1 Receptor Revenue (2021-2032)
  2. 9.2 Europe Bradykinin B1 Receptor Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bradykinin B1 Receptor Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bradykinin B1 Receptor Revenue by Type (2027-2032)
  5. 9.3 Europe Bradykinin B1 Receptor Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bradykinin B1 Receptor Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bradykinin B1 Receptor Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bradykinin B1 Receptor Revenue by Application (2027-2032)
  9. 9.5 Europe Bradykinin B1 Receptor Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bradykinin B1 Receptor Revenue by Country
  11. 9.6.1 Europe Bradykinin B1 Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bradykinin B1 Receptor Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bradykinin B1 Receptor Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Bradykinin B1 Receptor Revenue (2021-2032)
  2. 10.2 China Bradykinin B1 Receptor Revenue by Type (2021-2032)
  3. 10.2.1 China Bradykinin B1 Receptor Revenue by Type (2021-2026)
  4. 10.2.2 China Bradykinin B1 Receptor Revenue by Type (2027-2032)
  5. 10.3 China Bradykinin B1 Receptor Revenue Share by Type (2021-2032)
  6. 10.4 China Bradykinin B1 Receptor Revenue by Application (2021-2032)
  7. 10.4.1 China Bradykinin B1 Receptor Revenue by Application (2021-2026)
  8. 10.4.2 China Bradykinin B1 Receptor Revenue by Application (2027-2032)
  9. 10.5 China Bradykinin B1 Receptor Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bradykinin B1 Receptor Revenue (2021-2032)
  2. 11.2 Asia Bradykinin B1 Receptor Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bradykinin B1 Receptor Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bradykinin B1 Receptor Revenue by Type (2027-2032)
  5. 11.3 Asia Bradykinin B1 Receptor Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bradykinin B1 Receptor Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bradykinin B1 Receptor Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bradykinin B1 Receptor Revenue by Application (2027-2032)
  9. 11.5 Asia Bradykinin B1 Receptor Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bradykinin B1 Receptor Revenue by Country
  11. 11.6.1 Asia Bradykinin B1 Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bradykinin B1 Receptor Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bradykinin B1 Receptor Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bradykinin B1 Receptor Revenue (2021-2032)
  2. 12.2 SAMEA Bradykinin B1 Receptor Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bradykinin B1 Receptor Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bradykinin B1 Receptor Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bradykinin B1 Receptor Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bradykinin B1 Receptor Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bradykinin B1 Receptor Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bradykinin B1 Receptor Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bradykinin B1 Receptor Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bradykinin B1 Receptor Revenue by Country
  11. 12.6.1 SAMEA Bradykinin B1 Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bradykinin B1 Receptor Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bradykinin B1 Receptor Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst